Patents by Inventor Jonathan Craine

Jonathan Craine has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6323036
    Abstract: The present invention provides a reagent for extracting lead ions from a variety of biological matrices such as human whole blood that has been anticoagulated with either heparin or EDTA, and lyophilized human blood and bovine EDTA whole blood. The released lead is measured in situ with a calorimetric porphyrin reagent without further manipulation of the supernatant. The lead ion releasing reagent can be used in conjunction with a variety of assay formats for the determination of lead in various biological fluids.
    Type: Grant
    Filed: May 27, 1998
    Date of Patent: November 27, 2001
    Assignee: Bayer Corporation
    Inventors: Eddy Chapoteau, Bronislaw P. Czech, Jonathan Craine
  • Patent number: 5891736
    Abstract: The present invention provides a reagent for extracting lead ions from a variety of biological matrices such as human whole blood that has been anticoagulated with either heparin or EDTA, and lyophilized human blood and bovine EDTA whole blood. The released lead is measured in situ with a colorimetric porphyrin reagent without further manipulation of the supernatant. The lead ion releasing reagent can be used in conjunction with a variety of assay formats for the determination of lead in various biological fluids.
    Type: Grant
    Filed: November 20, 1996
    Date of Patent: April 6, 1999
    Assignee: Bayer Corporation
    Inventors: Eddy Chapoteau, Bronislaw P. Czech, Jonathan Craine
  • Patent number: 5814521
    Abstract: The present invention relates to a method for the determination of polyvalent metal ions using a sandwich aggregation assay. One or more chelating agents capable of forming at least 2:1 or higher ratio stoichiometry complexes with polyvalent metal ions are attached to a suitable carrier such as latex particles through covalent bonds or by non-covalent interactions, such as hydophobic interactions. Upon complexation with the metal ions, the carriers of the complexing agent aggregate, causing an increase in light absorbance or light scattering which is proportional to the concentration of metal ions in the test sample. The measurement of the light absorbance or light scattering by a suitable instrument, such as a spectrophotometer or nephelometer provides a means for measuring the concentration of metal ions.
    Type: Grant
    Filed: August 28, 1996
    Date of Patent: September 29, 1998
    Assignee: Bayer Corporation
    Inventors: Eddy Chapoteau, Jonathan Craine, Bronislaw P. Czech, Anand Kumar, Koon-wah Leong